John J. Alam - Aug 16, 2023 Form 3 Insider Report for CervoMed Inc. (DFFN)

Signature
/s/ John Alam, M.D.
Stock symbol
DFFN
Transactions as of
Aug 16, 2023
Transactions value $
$0
Form type
3
Date filed
8/23/2023, 09:52 PM
Next filing
Sep 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DFFN Common Stock 742K Aug 16, 2023 Direct F1
holding DFFN Common Stock 742K Aug 16, 2023 By Spouse F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock of the corporation then known as EIP Pharma, Inc. ("EIP") were converted (after giving effect to the conversion of each share of EIP's preferred stock and EIP's convertible promissory notes into EIP's common stock) into shares of the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of March 30, 2023, by and among the EIP, Dawn Merger Sub, Inc. and the Issuer (formerly known as Diffusion Pharmaceuticals, Inc.) (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of EIP common stock was exchanged for 0.1151 shares of the Issuer's common stock, after giving effect to a reverse split of the Issuer's common stock of 1-for-1.5.
F2 Consists of shares of capital stock held by Sylvie Gregoire, Pharm.D., the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.